Register Now - Every Drop Matters: Reducing Product Loss in Sterile Filtration
|Articles|January 27, 2015

SAFC Expands Irvine Facility

The new facility will feature dry powder cell-culture media capabilities.


SAFC Commercial, a branch of the Sigma-Aldrich Corporation, recently announced they are expanding their facility capabilities to provide redundancy to the dry powder manufacturing supply chain. The dry-powder milling and blending for cell-culture media that occurs at the Lenexa, Kansas facility will also occur in the Irvine, Scotland locations. Liquid cell-culture media, buffers, and reagents are already prepared at the Irvine site.

According to a press release, the facility expansion will allow SAFC to create shorter lead times, increase storage capacity for finished goods, and support projects from “early clinical development through commercial scale using a globally consistent approach across all cell culture media manufacturing sites,” said Gilles Cottier, president of SAFC.

Source:
PR Newswire


Related to this article

The BioPharm Brief: Long-Term Survival Data for a PD-L1/4-1BB Bispecific, Celldex Exits Atopic Dermatitis, and a Fc-Fusion GLP-1 Goes Global
Leads Biolabs details survival data and 2027 ADC combination plans for its PD-L1/4-1BB bispecific opamtistomig, Celldex Therapeutics ends its atopic dermatitis program for anti-KIT antibody barzolvolimab after a phase 2 miss, and Innogen licenses its Fc-fusion GLP-1 receptor agonist efsubaglutide alfa to Arcera Life Sciences for international markets.